| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |